ERA-NET: Innovate to Prevent: Personalized Prevention in Health and Care Service
The call aims to fund projects that implement personalized prevention strategies in health and care services, emphasizing person-centered approaches and the use of IT and digital technologies.
Its goal is to enhance various aspects of health and care systems, such as quality, efficiency, equity, and sustainability, ultimately improving citizens' quality of life while reducing the burden on services.
Budget: € 140,000 total.
Eligibility: Requires a consortium of 3-9 partners from the list of eligible countries.
Duration: 3 years.
Funding Agency: Israeli PI's are funded by the Chief Scientist Office of The Ministry of Health (CSO-MOH).
Ministry of Innovation, Science and Technology (MOST)
M-era.Net 2024
M-ERA.Net, a European initiative, supports partnerships in materials science and batteries to align with the European policy on greenhouse gas reduction. It fosters coordination between research programs, offering funding through consortia of countries and global funding organizations.
Focus Areas for This Call:
1. Sustainable advanced materials for energy 2. Innovative surfaces, coatings and interfaces 3. High performance composites 4. Functional materials 5. Materials addressing environmental challenges 6. Next-generation materials for advanced electronics
Budget: € 100,000 total.
Eligibility: Requires a consortium of 3-9 partners from the list of eligible countries.
Funding Agency: Israeli PI's are funded by the Chief Scientist Office of The Ministry of Health (CSO-MOH).
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
The call seeks proposals to enhance healthcare professional education on diagnosing Metallo-β-Lactamase (MBL) producing bacterial infections. It aims to address knowledge gaps and develop educational tools/programs for improved patient management.
This call seeks to fund investigators addressing critical gaps in type 1 diabetes research, fostering breakthroughs through innovative scientific inquiry. The JDRF views the SRA program track as a partnership enterprise between the JDRF and the PI, with meaningful interaction between the PI and the assigned JDRF scientist (e.g. cooperative development of the research plan)
This call seeks to support early career researchers in developing innovative projects focused on advancing therapeutic treatments for SCN2A-related disorders. It aims to facilitate breakthroughs in understanding and addressing these disorders through funding and guidance.
Increase chances of winning a grant and potential for future commercialization
If you are considering or in the process of writing a grant for a project with potential commercial applications in the BIO field, feel free to approach our unit for support and direction.
BIO field includes:
Pharma, Biotechnology, Diagnostics, Medical Device, Digital Health
Our support includes: •Assistance with defining the future product in terms of market needs, competitor and market analysis, business model etc.
•Defining important research milestones that can increase the potential for future commercialization.
*This is a service offered in collaboration with RDA*